lamivudine has been researched along with Hepatitis D in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Heller, T; Hercun, J; Koh, C | 1 |
| Agyingi, K; Domkam, I; Joyce, AN; Keou, CK; Mbu, RE; Moudourou, S; Nanfack, A; Njefi, K; Sosso, S; Takang, W; Takou, D; Torimiro, JN | 1 |
| Barreiro, P; Poveda, E; Soriano, V; Vispo, E | 1 |
| Forde, J; Hews, S; Kuang, Y; Packer, A | 1 |
| Boyd, A; Lacombe, K; Miailhes, P; Zoulim, F | 1 |
| Dorobantu, B; Gangone, E; Gheorghe, L; Hrehoret, D; Iacob, S; Matei, E; Popescu, I | 1 |
| Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I | 1 |
| Burroughs, A; Kalafateli, M; Nikolopoulou, V; Triantos, C | 1 |
| Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E | 1 |
| Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E | 1 |
| Enomoto, N; Hasegawa, K; Hashimoto, E; Hayashi, N; Joh, R; Tokushige, K; Torii, N; Watanabe, M; Yamashiro, T | 1 |
| Roche, B; Samuel, D | 1 |
| Agnelli, F; Caccamo, L; Donato, MF; Gatti, S; Maggi, U; Melada, E; Paone, G; Reggiani, P; Rossi, G | 1 |
| Bahr, MJ; Cornberg, M; Deterding, K; Hadem, J; Manns, MP; Metzler, F; Pothakamuri, SV; Schlaphoff, V; Wedemeyer, H | 1 |
| de Man, RA; Honkoop, P; Niesters, HG; van Nunen, AB; Vossen, AC; Wolters, LM; Zondervan, PE | 1 |
| Han, SH; Jensen, D; Keeffe, EB; Lok, AS; Luketic, V; Teo, EK; Terrault, N | 1 |
4 review(s) available for lamivudine and Hepatitis D
| Article | Year |
|---|---|
Hepatitis Delta: Prevalence, Natural History, and Treatment Options.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Global Health; Hepatitis D; Hepatitis delta Antigens; Hepatitis Delta Virus; Humans; Interferon alpha-2; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Organophosphonates; Prevalence; Risk; RNA, Viral; Serologic Tests | 2020 |
Hepatitis B in HIV-infected patients.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Resistance, Viral; Hepatitis B Vaccines; Hepatitis B, Chronic; Hepatitis D; HIV Infections; Humans; Lamivudine; Organophosphonates; Tenofovir | 2013 |
Meta-analysis: antiviral treatment for hepatitis D.
Topics: Antiviral Agents; Hepatitis D; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Lamivudine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load | 2012 |
Evolving strategies to prevent HBV recurrence.
Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis Antibodies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis D; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Analysis; Tissue Donors | 2004 |
1 trial(s) available for lamivudine and Hepatitis D
| Article | Year |
|---|---|
Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.
Topics: Adult; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Interferon-alpha; Lamivudine; Male; RNA, Viral | 2000 |
11 other study(ies) available for lamivudine and Hepatitis D
| Article | Year |
|---|---|
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cameroon; Coinfection; Drug Resistance, Viral; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis C; Hepatitis C Antibodies; Hepatitis D; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Young Adult; Zidovudine | 2018 |
Mathematical models of the interrelated dynamics of hepatitis D and B.
Topics: Cell Proliferation; Coinfection; Computer Simulation; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Lamivudine; Models, Immunological; Virus Replication | 2014 |
Potential effect of lamivudine-induced S gene mutations on liver-related pathogenesis in hepatitis D virus infection.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Lamivudine; Liver Transplantation; Mutation | 2017 |
Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
Topics: Adult; Comorbidity; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis D; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunotherapy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Program Evaluation; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Romania; Survival Analysis; Treatment Outcome | 2008 |
[Protocol for the antiviral therapy of hepatitis B and D].
Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2010 |
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult | 2012 |
Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy.
Topics: Adult; Antibodies, Viral; Antiviral Agents; DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Lamivudine; Male; RNA, Viral | 2003 |
Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection.
Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatitis B, Chronic; Hepatitis D; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Analysis | 2007 |
Clearance of chronic HCV infection during acute delta hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Hepatitis B; Hepatitis C, Chronic; Hepatitis D; Humans; Lamivudine; Liver Function Tests; Male; Substance Abuse, Intravenous; Superinfection | 2009 |
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
Topics: Antiviral Agents; Asia; Asian People; Drug Resistance; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; White People | 2001 |